Lipid-lowering therapy (LLT) in 1,100 cardiac rehabilitation patients with coronary heart disease: the LLT-R(ehabilitation) registry

Figures

• 

  Figure 1. Relative numbers of LLT for admission, discharge and two follow-ups. Results are shown for overall cohort (A, n = 1,100), stratified by sex (B,C, female: n = 262, male: n = 838), and age groups at baseline (D–F, age <50: n = 108, age 50–70: n = 622, age >70: n = 321). P-values show results from Cochran's Q-Test, comparing proportions over time.

• 

  Figure 2. Relative number of statin treatment for admission, discharge and two follow-ups. Results are shown for overall cohort. Valid data (i.e., non-missing values) was available for n = 980 patients at admission, n = 943 patients at discharge, n = 609 at 3-months-FU and n = 531 at 12-months-FU. P-values show results from Cochran's Q-Test, comparing proportions over time.

• 

  Figure 3. Simvastatin and atorvastatin dosages for admission, discharge and two follow-ups. Results are shown for overall cohort. Valid data (i.e., non-missing values) was available for n = 980 patients at admission, n = 943 patients at discharge, n = 609 at 3-months-FU and n = 531 at 12-months-FU.

• 

  Figure 4. LDL-C values for admission, discharge and two follow-ups. Results are shown for overall cohort (A, n = 1,100), stratified by sex (B,C, female: n = 262, male: n = 838), and age groups at baseline (D–F, age <50: n = 108, age 50–70: n = 622, age >70: n = 321). Regarding LDL-C, valid data (i.e., non-missing values) was available for n = 1,089 patients at admission, n = 363 patients at discharge, n = 533 at 3-months Fu and n = 523 at 12-months-FU. P-values show results from repeated measures ANOVA.

• 

  Figure 5. LDL-C ranges achieved at admission, discharge and two follow-ups. Results are shown for overall cohort (A, n = 1,100), stratified by sex (B,C, female: n = 262, male: n = 838), and age groups at baseline (D–F, age <50: n = 108, age 50–70: n = 622, age >70: n = 321). Regarding LDL-C, valid data (i.e., non-missing values) was available for n = 1,089 patients at admission, n = 363 patients at discharge, n = 533 at 3-months Fu and n = 523 at 12-months-FU.